What are the consequences of allowing Naloxone sales over the counter? Elizabeth Tracey reports

What are the consequences of allowing Naloxone sales over the counter? Elizabeth Tracey reports

Alcohol And Drug Abuse – Johns Hopkins Medicine Podcasts

Naloxone is pivotal in reversing opioid overdoses, and now the FDA has decided it can be sold without a prescription, so-called over the counter. Michael Fingerhood, a substance use disorder expert at Johns Hopkins,

InformativeEmpoweringHopefulEducationalEmpowering

1:042 Oct 2023

RSS Feed

Naloxone Over the Counter: A Lifeline or a Barrier?

Episode Overview

  • The episode explores the FDA's decision to allow over-the-counter sales of naloxone.
  • Michael Fingerhood, a substance use disorder expert at Johns Hopkins, raises concerns about the potential downsides of this decision.
  • Fingerhood discusses the impact of cost on naloxone accessibility and the potential reduction in free naloxone availability.
  • Naloxone's critical role in preventing opioid-related fatalities is highlighted, emphasising its importance as a life-saving medication.
  • The episode provides valuable insights into the implications of the FDA's decision and its potential consequences for naloxone accessibility.
Naloxone is easy to administer and has saved millions of lives that may have been lost to opioid overdoses.

Imagine having a life-saving medication within reach, but it comes with strings attached. This episode of the Johns Hopkins Medicine podcast dives into the FDA's recent decision to make naloxone available over the counter. Naloxone is a critical tool in reversing opioid overdoses, but what happens when it's sold without a prescription? Michael Fingerhood, a substance use disorder expert at Johns Hopkins, sheds light on this complex issue.

He raises valid concerns about the potential downsides, such as the high cost of naloxone and how it might limit access to free versions of the drug. Fingerhood stresses the life-saving importance of naloxone, but also questions if making it over-the-counter could inadvertently reduce its availability to those who need it most. This episode offers a balanced view, exploring both the benefits and the potential pitfalls of this FDA decision.

Whether you're directly affected by opioid issues or just interested in public health, this discussion provides crucial insights into the ongoing battle against opioid overdoses.

Podcast buttons

Do you want to link to this podcast?
Get the buttons here!

More From This Show

The latest episodes from the same podcast.

Related Episodes

Similar episodes from other shows in the catalogue.